CoreWeave, Inc. - Class A Common Stock (CRWV)

Berkshire Hathaway bought $1.6 billion of United Health stock in Q2. Inflation may be ticking higher after all.

A trio of persistent concerns point to a further retreat for Supermicro.

The company reported revenue growth exceeding 200% in its most recently completed quarter.

The AI infrastructure company pointed to demand that exceeds supply.

CoreWeave insiders are selling shares post-IPO lockup. Analysts and influential institutional investors are stepping in.

CoreWeave and Nebius are both crucial players in the AI infrastructure market.

AI companies like CoreWeave and Nebius are seeing stock prices decline this week.

CoreWeave shares are trading flat Thursday morning. The stock is flat after an earlier surge following news of a significant investment.

These two stocks have benefited significantly from a surge in demand due to artificial intelligence.

CoreWeave, which went public in late March, has seen its initial public offering (IPO) lockup period expiring after the close of trading on Aug. 14.

CoreWeave shares are rising in Wednesday's after-hours session after Jane Street took a passive stake in the company.

Investors can add the fall-out from a MIT study on what's pressuring artificial stocks. AI stocks tumbled again on Wednesday.

Nvidia increases its position in CoreWeave.

Nvidia stock has pulled back from recent highs amid concerns of a bubble in artificial intelligence stocks.

The company is planning on spending over $20 billion on capital expenditures in 2025 to meet the soaring demand from its customers.

Nebius Group has surprised investors with a 200% rally compared to CoreWeave since hitting its low on June 9.

This AI infrastructure play has delivered bigger gains than its larger peers since going public earlier this year.

Nvidia's public investments are highly concentrated in two unique and rapidly growing AI titans.

CoreWeave Inc (NASDAQ:CRWV) shares are trading lower Tuesday, adding to losses of nearly 40% over the past week. Here's a look at what's going on.

Can this high-growth AI stock outrun its mounting debt?

The short-seller who called the Enron fraud has a pessimistic take on 2025's hottest IPO.